標題
返回
確定
Topics
Business
Business
PR Newswire
AI & Semiconductor
AI & Semiconductor
Taiwan
Taiwan
Politics
Defense
Life
China
China
World
World
Editorial
Editorial
Topics
Business
Business
PR Newswire
AI & Semiconductor
AI & Semiconductor
Taiwan
Taiwan
Politics
Defense
Life
China
China
World
World
Editorial
Editorial
Business
AI & Semiconductor
Taiwan
China
World
Editorial
Business
AI & Semiconductor
Taiwan
China
World
Editorial
Business
AI & Semiconductor
Taiwan
China
World
Editorial
Home
license agreement
#
license agreement
About 3 search results
Sort by Date
Business
PR Newswire
Abbisko Therapeutics Deepens R&D Collaboration with Lilly
SHANGHAI
PR Newswire
2026-06-24 09:00
Abbisko Therapeutics
Eli Lilly
R&D collaboration
Business
PR Newswire
Haisco Enters into Exclusive License Agreement with Nuvectis for Two Drug Candidates in Oncology and Complement Indications
BEIJING
PR Newswire
2026-06-23 21:17
Haisco
Nuvectis
license agreement
Business
PR Newswire
Antengene Announces Exclusive License Agreement with MPM BioImpact-Established K2 Therapeutics for ATG-106 and Option for Undisclosed Bispecific TCE
BOSTON, SINGAPORE and HONG KONG
PR Newswire
2026-06-22 08:30
Antengene
K2 Therapeutics
ATG-106